Drugs / Cetaphil Healing Ointment
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06015217 | Aug → Dec 2023 | — | Galderma R&D | Completed | No outcome recorded |
| Phase 4 | NCT05686928 | Aug → Oct 2022 | — | Galderma R&D | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cetaphil Healing Ointment | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06015217 ↗ |
| Route | Topical | “Topical ointment application twice daily” NCT05686928 ↗ |